GENE ONLINE|News &
Opinion
Blog

2023-03-06| In-Depth

Industrializing iPSC and Harnessing its Medical Applications – An Interview with Dr. Hong-Lin Su

by GeneOnline
Share To
Featured in the special topic of Gene and Cell Therapy, GeneOnline is honored to interview Professor Hong-Lin Su from the Department of Life Sciences at National Chung Hsing University, who is one of the few induced pluripotent stem cell (iPSC) experts in the field of cell therapy in Taiwan, with experience in academia, industry, and clinical practice.

The technology of neural differentiation from pluripotent stem cells developed by Prof. Su’s team not only won the National Innovation Award in 2017 but was also successfully patented in Taiwan, the US, and Japan. During the interview, Prof. Su introduced the principle of iPS cell therapy and its current clinical applications. He also shared his rich experience accelerating the formation of Taiwan's cell therapy industry chain by establishing DuoGenic Stem Cells in recent years.

It's free! Log in now to read

LATEST
Google DeepMind Open-Sources AlphaFold 3: A Game-Changer for Drug Discovery and Biotech
2024-11-12
Hiroaki Ueno: Leading Japan’s Pharma Revolution with Innovation and Global Strategy
2024-11-12
Japan’s Bio-Economy Push: A Future Driven by Innovation and Global Collaboration
2024-11-12
Opening the Door to ‘Designer Babies’? South Africa’s Genome Editing Guidelines Spark Global Debate
2024-11-08
Infinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial
2024-11-08
United Imaging Receives First Approval in Canada
2024-11-07
BioNTech’s Bold Move: Rwanda’s New mRNA Vaccine Factory Set to Boost African Healthcare
2024-11-06
EVENT
2024-12-05
8th Healthcare Expo Taiwan
Taipei, Taiwan
Scroll to Top